¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary effusion lymphoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary affect hunger
    ÀÏÂ÷Á¤µ¿°¥¸Á, ÀÏÂ÷¾ÖÁ¤°¥¸Á
  • primary aldosteronism
    ¿ø¹ß¾Ëµµ½ºÅ×·ÐÁõ
  • primary amebic meningoencephalitis
    ¿ø¹ß¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • primary amenorrhea
    ¿ø¹ß¹«¿ù°æ
  • primary amnion
    ÀÏÂ÷¾ç¸·, ¿ø½Ã¾ç¸·
  • primary amyloidosis
    ¿ø¹ß¾Æ¹Ð·ÎÀ̵åÁõ
  • primary aqueous
    ÀÏÂ÷¹æ¼ö, ¿ø¹æ¼ö
  • primary atelectasis
    ¿ø¹ß¹«±âÆó
  • primary atypical pneumonia
    ¿ø¹ßºñÁ¤ÇüÆó·Å
  • primary biliary cirrhosis
    ¿ø¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
  • primary bronchus
    ÀÏÂ÷±â°üÁö
  • primary cancer
    ¿ø¹ß¾Ï
  • primary carcinoma
    ¿ø¹ß¾ÏÁ¾
  • primary cardiomyopathy
    ¿ø¹ß½ÉÀå±ÙÀ°º´(Áõ), ¿ø¹ß½É±Ùº´(Áõ)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary coil
    ÀÏÂ÷ÄÚÀÏ
  • primary complex
    Ãʱ⺯ȭ±º, ¿ø¹ßº¹ÇÕü
  • primary constriction
    (¢¡centromere) ¸Åµì, µ¿¿øÃ¼, Áß½ÉÀý
  • primary contact
    ÀÏÂ÷Á¢ÃË
  • primary culture
    óÀ½½É±â
  • primary biliary cirrhosis
    ¿ø¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • primary health care
    ÀÏÂ÷º¸°ÇÀÇ·á
  • primary inoculation complex
    ¿ø¹ßÁ¢Á¾º¹ÇÕü
  • primary ossification center
    ÀÏÂ÷»ÀµÇ±âÁß½É, ÀÏÂ÷°ñÈ­Áß½É
  • primary sex character
    ÀÏÂ÷¼ºÂ¡
  • delayed primary suture
    Áö¿¬ÀÏÂ÷ºÀÇÕ
  • primary dentin
    ÀÏÂ÷»ó¾ÆÁú
  • primary dentition
    (¢¡deciduous tooth) Á¥´Ï, Å»¶ôÄ¡¾Æ
  • primary depression
    ÀÏÂ÷¿ì¿ïÁõ
  • primary dysmenorrhea
    ¿ø¹ß¿ù°æÅë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pneumonia, primary atypical
    ¿ø¹ß¼º ºñÁ¤ÇüÆó·Å
  • premaxilla [primary palate]
    ¾ÕÀ§ÅλÀ (ÀÏÂ÷ÀÔõÀå)
  • primary
    ¿ø¹ß¼º(ê«Û¡àõ)ÀÇ
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary abdominal implantation
    ÀÏÂ÷¹è¾ÈÂø»ó
  • primary acquired cholesteatoma
    ÀÏÂ÷(¼º) ÈÄõ(¼º) ÁøÁÖÁ¾
  • primary action
    ÀÏÂ÷±â´É
  • primary action; main action
    ÁÖÀÛ¿ë, ÀÏÂ÷ÀÛ¿ë.
  • primary adaptation
    ÀÏÂ÷(¼º) ¼øÀÀ(ìéó­àõâ÷ëë).
  • primary adhesion
    ÀÏÂ÷(¼º) À¯Âø(¡­ë¨ó·).
  • primary affect hunger
    ÀÏÂ÷¼º¡¡¾ÖÁ¤°¥¸Á£®
  • primary aldosteronism
    ¿ø¹ß(¼º) ¾Ëµµ½ºÅ×·ÐÁõ(ê«Û¡àõ¡­ñø).
  • primary aldosteronism
    ¿ø¹ß(¼º) ¾Ëµµ½ºÅ×·ÐÁõ(ê«Û¡(àõ)¡­ñø)
  • primary amenorrhea
    ¿ø¹ß¼º ¹«¿ù°æ(ê«Û¡àõÙíêÅÌè), 1Â÷¼º ¹«¿ù°æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • subdural effusion
    °æ¸·ÇÏ»ïÃâ(¡­ß¶õó).
  • subdural effusion
    °æ¸·ÇÏ»ïÃâ(¡­ß¶õó)
  • synovial effusion
    Ȱ¾×»ïÃâ¾×
  • tuberculous pericardial effusion
    °áÇÙ¼º ½É³¶»ïÃâ¾×(¡­ãýҥ߶õóäû).
  • uveal effusion
    Æ÷µµ¸·»ïÃâ
  • adult t-cell leukemia/lymphoma
    ¼º¼÷ T-¼¼Æ÷ ¹éÇ÷º´/¸²ÇÁÁ¾(à÷âÙ¡­á¬øà ÛÜúìÜ»/¡­ðþ)
  • angiotropic (intravascular) large cell lymphoma
    Ç÷°ü¿µ¾ç¼º(Ç÷°ü³»)´ë¼¼Æ÷¸²ÇÁÁ¾
  • atypical lymphoma
    ÀÌÇü<ºñÁ¤Çü>¸²ÇÁÁ¾(?Ì¡).
  • burkitts lymphoma
    ¹öŰƮ¸²ÇÁÁ¾(¡­ðþ)
  • burkitts lymphoma,epstein-barr virus
    ¿¦½ºÅ¸ÀÎ-¹Ù ¹ÙÀÌ·¯½º
  • cutaneous B cell lymphoma
    ÇǺΠB¼¼Æ÷¸²ÇÁÁ¾
  • cutaneous T cell lymphoma
    ÇǺΠT ¼¼Æ÷¸²ÇÁÁ¾.
  • cutaneous T cell lymphoma
    ÇǺΠT ¼¼Æ÷¸²ÇÁÁ¾
  • cutaneous t cell lymphoma
    ÇǺΠT ¼¼Æ÷¸²ÇÁÁ¾(ù«Ý±¡­ðþ)
  • giant follicular lymphoma
    °Å´ë¿©Æ÷¼º ¸²ÇÁÁ¾.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Primary amnion
    ÀÏÂ÷¾ç¸·
    [¿¾ ¿ë¾î] ÀÏÂ÷¾ç¸·
  • Primary villus
    ÀÏÂ÷À¶¸ð
    [¿¾ ¿ë¾î] ÀÏÂ÷À¶¸ð
  • Primary pregnancy
    ÀÏÂ÷ÀÓ½Å
    [¿¾ ¿ë¾î] ÀÏÂ÷ÀÓ½Å
  • Primary spermatocyte
    ÀÏÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷Á¤¸ð¼¼Æ÷
  • Primary spermatocyte
    ÀÏÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] Á¦ÀÏÁ¤¸ð¼¼Æ÷
  • Primary nasal septum
    ÀÏÂ÷ÄÚÁß°Ý
    [¿¾ ¿ë¾î] ÀÏÂ÷ºñÁß°Ý
  • Primary hair follicle
    ÀÏÂ÷ÅÐÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷¸ð³¶
  • Primary sponge bone
    ÀÏÂ÷ÇØ¸é»À
    [¿¾ ¿ë¾î] ÀÏÂ÷ÇØ¸é°ñ
  • Primary pulmonary lobule
    ÀÏÂ÷ÇãÆÄ¼Ò¿±
    [¿¾ ¿ë¾î] ÀÏÂ÷Æó¼Ò¿±
  • Primary septum
    ù°»çÀ̸·
    [¿¾ ¿ë¾î] Á¦ÀÏÁß°Ý
  • Primary fissure
    ù°ƴ»õ
    [¿¾ ¿ë¾î] Á¦1·Ä
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary structure
    ÀÏÂ÷±¸Á¶(ìéó­Ï°ðã)
  • primary tissue culture
    ÀÏÂ÷ Á¶Á÷¹è¾ç(ìéó­ðÚòÄÛÆå×)
  • primary transcript
    ÀÏÂ÷ Àü»çü(ìéó­ï®ÞÐô÷)
  • primary tumor
    ¿ø¹ß¼º Á¾¾ç(ê«Û¡àõðþåË)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PCCM pediatric critical care medicine; primary care case management; primary care case manager
PCP parachlorophenate; patient care plan; pentachlorophenol; 1-(1-phenylcyclohexyl)piperidine; periphera...
PH parathyroid hormone; partial hepatectomy; partial hysterectomy; passive hemagglutination; past histo...
PHC personal health costs; posthospital care; premolar hypodontia, hyperhidrosis, [premature] canities [...
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
P.E. Pericardial effusion
PE Pleural effusion
ARL AIDS)-related lymphoma
ATL Adult T cell leukaemia-lymphoma
ATLL Adult T cell leukemia/lymphoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primary afferent axon
    ÀÏÂ÷ ±¸½É¼º Ãà»è
  • primary afferent cell body
    ÀÏÂ÷ ±¸½É¼º ¼¼Æ÷ü
  • primary afferent fiber
    ÀÏÂ÷ ±¸½É ¼¶À¯
  • primary afferent nociceptive transmitter
    ÀÏÂ÷ ±¸½É À¯ÇØ ¼ö¿ë¼º Àü´Þ ¹°Áú
  • primary afferent nociceptor input
    ÀÏÂ÷ ±¸½É¼º Ä§ÇØ¼ö¿ëü ÀÔ·Â, ÀÏÂ÷ ±¸½É¼º À¯Çؼö¿ë±â ÀÔ·Â
  • primary afferent projection
    ÀÏÂ÷ ±¸½É¼º Åõ»ç
  • primary afferent terminal
    ÀÏÂ÷ ±¸½É¼º ¸»´Ü
  • primary amenorrhea
    ¿ø¹ß ¹«¿ù°æ, ¿ø¹ß¼º ¹«¿ù°æ
  • primary amyloidosis
    ¿ø¹ß¼º À¯ÀüºÐÁõ, ¿ø¹ß ¾Æ¹Ð·ÎÀ̵åÁõ, ¿ø¹ß¼º ¾Æ¹Ð·ÎÀ̵åÁõ
  • primary anesthesia
    ÀÏÂ÷ ¸¶Ãë
  • primary benign leukoplakias
    ¿ø¹ß¼º ¾ç¼º ¹é¹ÝÁõ
  • primary bond
    ÀÏÂ÷ °áÇÕ
    ÀϹÝÀûÀ¸·Î À̿ °áÇÕ, °øÀ¯ °áÇÕ, ¹èÀ§ °áÇÕ, ±Ý¼Ó °áÇÕ µîÀ» ¸»ÇÏ¸ç °áÇÕ·ÂÀÌ °¡Àå °­ÇÏ´Ù
  • primary bullous dermatoses
    ¿ø¹ß ¼öÆ÷¼º ÇǺκ´
  • primary carcinoma
    ¿ø¹ß ¾ÏÁ¾
  • primary cement
    ÀÏÂ÷ ½Ã¸àÆ®Áú, Á¦ÀÏ ½Ã¸àÆ®Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
nodular histiocytic lymphoma <tumour> A B-cell lymphoma with nodular or diffuse lymph node or bone marrow involvement by large lymphoid cells.
Synonym: follicular predominantly small cleaved cell lymphoma, nodular histiocytic lymphoma.
(05 Mar 2000)
nodular lymphoma <tumour> A malignant lymphoma arising from lymphoid follicular B-cells which may be small or large, growing in a nodular pattern.
Synonym: follicular lymphoma, giant follicular lymphoblastoma.
(05 Mar 2000)
non-Hodgkin's lymphoma <oncology, tumour> A group of lymphomas which differ in important ways from Hodgkin's disease and are classified according to the microscopic appearance of the cancer cells. The disease is classified as either low grade (slowly growing), intermediate grade or high grade (rapidly growing) and may be treated in a variety of ways depending on the exact diagnosis. Previously called lymphosarcoma.
(30 Sep 1997)
diffuse small cleaved cell lymphoma <tumour> A diffuse poorly differentiated lymphocytic lymphoma; follicular centre cell lymphoma that lacks a follicular pattern; malignancy is of intermediate grade.
(05 Mar 2000)
immunoblastic lymphoma <tumour> A monomorphous proliferation of immunoblasts involving the lymph nodes; it may develop in some patients with angioimmunoblastic lymphadenopathy.
(05 Mar 2000)
T-cell lymphoma A cancer of the immune system that appears in the skin; also called mycosis fungoides.
(12 Dec 1998)
T-cell-rich, B-cell lymphoma <tumour> A B-cell lymphoma in which more than 90% of the cells are of T-cell origin, masking the large cells that form the neoplastic B-cell component.
See: adult T-cell lymphoma.
(05 Mar 2000)
extra nodal lymphoma <oncology, tumour> Literally outside the lymph nodes, but exhibiting the characteristics of lymph node cancer. A term used to describe the extent and site of disease.
(27 Sep 1997)
Ki-1+ lymphoma <tumour> A form of lymphoma characterised by anaplasia of cells, sinusoidal growth, and immunoreactivity with CD30 (Ki-1 or Ber-H2).
Synonym: Ki-1+ lymphoma.
(05 Mar 2000)
follicular lymphoma <tumour> A malignant lymphoma arising from lymphoid follicular B-cells which may be small or large, growing in a nodular pattern.
Synonym: follicular lymphoma, giant follicular lymphoblastoma.
(05 Mar 2000)
follicular predominantly large cell lymphoma <tumour> A B-cell lymphoma of intermediate malignancy.
(05 Mar 2000)
follicular predominantly small cleaved cell lymphoma <tumour> A B-cell lymphoma with nodular or diffuse lymph node or bone marrow involvement by large lymphoid cells.
Synonym: follicular predominantly small cleaved cell lymphoma, nodular histiocytic lymphoma.
(05 Mar 2000)
large cell lymphoma <oncology, tumour> Highly malignant group of tumours arising from transformed lymphocytes or myeloid precursors. Cell of origin often obscure.
(18 Nov 1997)
Lennert's lymphoma <tumour> Malignant lymphoma with a high proportion of diffusely scattered epithelioid cells, tonsillar involvement, and an unpredictable course.
Synonym: Lennert's lesion.
(05 Mar 2000)
lymphoblastic lymphoma <tumour> A diffuse lymphoma in children, with supradiaphragmatic distribution and T lymphocytes having convoluted nuclei; many patients develop acute lymphoblastic leukaemia.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary stress
    =PRIMARY ACCENT
  • primary structure
    ÃÊ¿øÀû ±¸Á¶¹°(ÃÖ¼ÒÇÑÀÇ Á¶Çü ¼ö´ÜÀ¸·Î Á¦À۵Ǵ ÀüÀ§ Á¶°¢)
  • primary tenses
    (¶óƾ,±×¸®½º¾îÀÇ) Á¦ 1½ÃÁ¦(ÇöÀç,¹Ì·¡,°ú°Å ¶Ç´Â ¿Ï·áÀÇ ÃÑĪ)
  • primary wall
    (¼¼Æ÷¸·ÀÇ) 1Â÷¸·
  • runoff primary
    °á¼± ÅõÇ¥(µÎ ÃÖ°í µæÇ¥ÀÚÁß Áö¸í È帰¡ µÉ »ç¶÷À» Á¤ÇÏ´Â)
  • white primary
    ¹éÀÎ ¿¹¼±È¸(¹Ì±¹ ³²ºÎ ¿©·¯ ÁÖÀÇ ¹éÀθ¸ÀÌ ÅõÇ¥ÇÏ´ø ¹ÎÁÖ´çÀÇ ¿¹ºñ ¼±°Å)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á